106 related articles for article (PubMed ID: 32652329)
21. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
[No Abstract] [Full Text] [Related]
22. COVID-19: implications for immunosuppression in kidney disease and transplantation.
Kronbichler A; Gauckler P; Windpessl M; Il Shin J; Jha V; Rovin BH; Oberbauer R
Nat Rev Nephrol; 2020 Jul; 16(7):365-367. PubMed ID: 32409782
[TBL] [Abstract][Full Text] [Related]
23. Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod.
Mallucci G; Zito A; Fabbro BD; Bergamaschi R
Mult Scler Relat Disord; 2020 Oct; 45():102414. PubMed ID: 32711296
[No Abstract] [Full Text] [Related]
24. Effects of disruption from COVID-19 on antimalarial strategies.
Ansumana R; Sankoh O; Zumla A
Nat Med; 2020 Sep; 26(9):1334-1336. PubMed ID: 32807937
[No Abstract] [Full Text] [Related]
25. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
Takami A
Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895
[No Abstract] [Full Text] [Related]
26. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(697):1218-1219. PubMed ID: 32520464
[No Abstract] [Full Text] [Related]
27. The Possible Protective Role of α-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease.
Ait Wahmane S; Achbani A; Ouhaz Z; Elatiqi M; Belmouden A; Nejmeddine M
Mov Disord; 2020 Aug; 35(8):1293-1294. PubMed ID: 32519352
[No Abstract] [Full Text] [Related]
28. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and Hypercoagulability.
Sholzberg M
Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
[No Abstract] [Full Text] [Related]
30. COVID-19 and implications for thiopurine use.
Goodsall TM; Costello SP; Bryant RV
Med J Aust; 2020 Jun; 212(10):490-490.e1. PubMed ID: 32400020
[No Abstract] [Full Text] [Related]
31. Treating COVID-19 with colchicine in community healthcare setting.
Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
[No Abstract] [Full Text] [Related]
32. [Not Available].
Meylan P
Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
[No Abstract] [Full Text] [Related]
33. A plea for the pathogenic role of immune complexes in severe Covid-19.
Vuitton DA; Vuitton L; Seillès E; Galanaud P
Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
[No Abstract] [Full Text] [Related]
34. Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients.
Liao S; Zhan K; Gan L; Bai Y; Li J; Yuan G; Cai Y; Zhang A; He S; Mei Z
Signal Transduct Target Ther; 2020 Oct; 5(1):255. PubMed ID: 33130825
[No Abstract] [Full Text] [Related]
35. COVID-19 as a cause of immune thrombocytopenia.
Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
[No Abstract] [Full Text] [Related]
36. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
37. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
38. [Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?].
Ben Dhia A; Hamzaoui S; Mouaffak F
Encephale; 2020 Jun; 46(3S):S123-S124. PubMed ID: 32317164
[No Abstract] [Full Text] [Related]
39. N-acetylcysteine as a potential treatment for COVID-19.
Jorge-Aarón RM; Rosa-Ester MP
Future Microbiol; 2020 Jul; 15():959-962. PubMed ID: 32662664
[No Abstract] [Full Text] [Related]
40. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission.
Lighter J; Phillips M; Hochman S; Sterling S; Johnson D; Francois F; Stachel A
Clin Infect Dis; 2020 Jul; 71(15):896-897. PubMed ID: 32271368
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
